Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/treatment-of-breast-cancer-brain-metastases-0WU7xDRBFL
References (71)
-
O. Salazar, R. Risco (1988)
Breast Cancer: Metastatic Patterns and Their PrognosisSouthern Medical Journal, 81
-
C. Anders, R. Nanda, M. Liu, K. Blackwell, C. Poznak, V. Abramson, A. Storniolo, N. Lin, V. Stearns, A. Melhem, S. Puhalla, J. Carpenter, M. Melisko, A. Deal, C. Hudis, E. Winer, C. Perou, C. Bradley, A. Wolff, L. Carey (2011)
TBCRC 018: Phase II study of iniparib plus chemotherapy to treat triple-negative breast cancer (TNBC) brain metastases (BM).Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 15_suppl
-
NU Lin, E Claus, J Sohl (2008)
Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastasesCancer, 113
-
AJ Clayton, S. Danson, S. Jolly, W. Ryder, P. Burt, A. Stewart, P. Wilkinson, R. Welch, B. Magee, G. Wilson, A. Howell, AM Wardley (2004)
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancerBritish Journal of Cancer, 91
-
J. Drappatz, A. Brenner, S. Rosenfeld, M. Groves, T. Mikkelsen, D. Schiff, J. Sarantopoulos, E. Wong, P. Wen, J. Castaigne (2010)
ANG1005: Results of a phase I study in patients with recurrent malignant glioma.Journal of Clinical Oncology, 28
-
W. Jacot, M. Gerlotto-Borne, S. Thézénas, S. Pouderoux, S. Poujol, M. About, G. Romieu (2010)
Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective studyBMC Cancer, 10
-
J. Hoffmann, I. Vitale, B. Buchmann, L. Galluzzi, W. Schwede, L. Senovilla, W. Skuballa, S. Vivet, R. Lichtner, J. Vicencio, T. Panaretakis, G. Siemeister, H. Lage, Lisa Nanty, S. Hammer, Kevin Mittelstaedt, S. Winsel, J. Eschenbrenner, M. Castedo, Carine Demarche, U. Klar, G. Kroemer (2008)
Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone.Cancer research, 68 13
-
V Franciosi, G Cocconi, M Michiara (1999)
Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective studyCancer, 85
-
D. Andrews, C. Scott, P. Sperduto, A. Flanders, L. Gaspar, M. Schell, M. Werner-Wasik, W. Demas, J. Ryu, J. Bahary, L. Souhami, M. Rotman, M. Mehta, W. Curran (2004)
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialThe Lancet, 363
-
I. Kokufu, T. Tanei, H. Taniguchi, F. Kimura, K. Fukuda, Masayuki Yamamoto, T. Yano, Katsumi Yamada (2002)
[A case of effective paclitaxel therapy for adriamycin resistant metastatic breast cancer with brain metastases].Gan to kagaku ryoho. Cancer & chemotherapy, 29 4
-
E. Bullitt, N. Lin, J. Smith, D. Zeng, Eric Winer, L. Carey, Weili Lin, M. Ewend (2007)
Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study.Radiology, 245 3
-
D. Rosner, T. Nemoto, W. Lane (1986)
Chemotherapy induces regression of brain metastases in breast carcinomaCancer, 58
-
D. Peereboom, J. Supko, K. Carson, T. Batchelor, S. Phuphanich, G. Lesser, T. Mikkelson, J. Fisher, S. Desideri, Xiaoying He, S. Grossman, The Consortium (2010)
A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomasJournal of Neuro-Oncology, 100
-
A. Eichler, I. Kuter, P. Ryan, L. Schapira, J. Younger, J. Henson (2008)
Survival in patients with brain metastases from breast cancerCancer, 112
-
P. Morrow, S. Divers, L. Provencher, S. Luoh, T. Petrella, M. Giurescu, L. Fielding, Y. Wang, G. Hortobagyi, L. Vahdat (2009)
Phase II study of sagopilone (ZK-Epo) in patients with recurrent metastatic breast cancer (MBC).Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 15_suppl
-
Stephanie Hines, L. Vallow, W. Tan, R. McNeil, E. Perez, Anudh Jain (2008)
Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 19 9
-
B. Besse, S. Lasserre, P. Compton, Jane Huang, S. Augustus, U. Rohr (2009)
Bevacizumab Safety in Patients with Central Nervous System MetastasesClinical Cancer Research, 16
-
N. Lin, W. Eierman, R. Greil, M. Campone, B. Kaufman, K. Steplewski, S. Lane, D. Zembryki, S. Rubin, E. Winer (2011)
Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastasesJournal of Neuro-Oncology, 105
-
N. Lin, E. Claus, J. Sohl, A. Razzak, A. Arnaout, Eric Winer (2008)
Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancerCancer, 113
-
S. Dawood, K. Broglio, F. Esteva, W. Yang, S. Kau, R. Islam, Constance Albarracin, T. Yu, Marjorie Green, G. Hortobagyi, A. González-Angulo (2009)
Survival among women with triple receptor-negative breast cancer and brain metastases.Annals of oncology : official journal of the European Society for Medical Oncology, 20 4
-
M. Trudeau, M. Crump, D. Charpentier, L. Yelle, L. Bordeleau, S. Matthews, E. Eisenhauer (2006)
Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG).Annals of oncology : official journal of the European Society for Medical Oncology, 17 6
-
M. Ewend, D. Morris, L. Carey, Alim Ladha, S. Brem (2008)
Guidelines for the initial management of metastatic brain tumors: role of surgery, radiosurgery, and radiation therapy.Journal of the National Comprehensive Cancer Network : JNCCN, 6 5
-
N. Lin, L. Carey, Minetta Liu, J. Younger, S. Come, M. Ewend, G. Harris, E. Bullitt, A. Abbeele, J. Henson, Xiaochun Li, R. Gelman, H. Burstein, E. Kasparian, D. Kirsch, Ann Crawford, F. Hochberg, E. Winer (2008)
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 12
-
E. Perez, E. Romond, V. Suman, Jong-Hyeon Jeong, N. Davidson, C. Geyer, S. Martino, E. Mamounas, P. Kaufman, N. Wolmark (2011)
Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 25
-
C. Donawho, Yan Luo, Yanping Luo, T. Penning, J. Bauch, J. Bouska, Velitchka Bontcheva-Diaz, B. Cox, T. DeWeese, L. Dillehay, D. Ferguson, N. Ghoreishi-Haack, D. Grimm, R. Guan, E. Han, R. Holley-Shanks, B. Hristov, K. Idler, K. Jarvis, Eric Johnson, L. Kleinberg, V. Klinghofer, Loren Lasko, X. Liu, K. Marsh, T. Mcgonigal, J. Meulbroek, A. Olson, J. Palma, L. Rodriguez, Yan Shi, Jason Stavropoulos, Alan Tsurutani, G. Zhu, S. Rosenberg, V. Giranda, D. Frost (2007)
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor ModelsClinical Cancer Research, 13
-
T. Yau, C. Swanton, S. Chua, A. Sue, G. Walsh, A. Rostom, S. Johnston, M. O'Brien, I. Smith (2006)
Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumabActa Oncologica, 45
-
C. Anders, B. Adamo, A. Deal, C. Livasy, H. Meng, E. Burrows, K. Fritchie, K. Blackwell, J. Geradts, M. Ewend, L. Carey, Ryan Miller (2010)
Abstract P1-14-01: Phosphatidylinositol 3-Kinase (PI3K) Pathway Activation in Breast Cancer Brain MetastasesCancer Research, 70
-
J. Bendell, S. Domchek, H. Burstein, L. Harris, J. Younger, I. Kuter, C. Bunnell, M. Rue, R. Gelman, E. Winer (2003)
Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinomaCancer, 97
-
C Christodoulou, D Bafaloukos, H Linardou (2005)
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II studyJ Neurooncol, 71
-
P. Schmid, P. Kiewe, K. Possinger, A. Korfel, S. Lindemann, M. Giurescu, S. Reif, H. Wiesinger, E. Thiel, D. Kühnhardt (2010)
Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors.Annals of oncology : official journal of the European Society for Medical Oncology, 21 3
-
Karen Kaiser, G. Rauscher, E. Jacobs, Teri Strenski, Carol Ferrans, R. Warnecke (2010)
The Import of Trust in Regular Providers to Trust in Cancer Physicians among White, African American, and Hispanic Breast Cancer PatientsJournal of General Internal Medicine, 26
-
A. Miller, B. Hoogstraten, M. Staquet, A. Winkler (1981)
Reporting results of cancer treatmentCancer, 47
-
E. Chang, J. Wefel, K. Hess, P. Allen, F. Lang, D. Kornguth, R. Arbuckle, J. Swint, A. Shiu, M. Maor, C. Meyers (2009)
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.The Lancet. Oncology, 10 11
-
M. Kocher, R. Soffietti, U. Abacioglu, S. Villà, F. Fauchon, B. Baumert, L. Fariselli, T. Tzuk-Shina, R. Kortmann, C. Carrie, M. Hassel, M. Kouri, E. Valeinis, D. Berge, S. Collette, L. Collette, R. Mueller (2011)
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 2
-
H. Stemmler, S. Kahlert, W. Siekiera, M. Untch, Bernhard Heinrich, V. Heinemann (2006)
Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer.Breast, 15 2
-
E. Bullitt, M. Ewend, S. Aylward, Weili Lin, G. Gerig, S. Joshi, I. Jung, K. Muller, Keith Smith (2004)
Abnormal Vessel Tortuosity as a Marker of Treatment Response of Malignant Gliomas: Preliminary ReportTechnology in Cancer Research & Treatment, 3
-
J. Engel, R. Eckel, Ü. Aydemir, S. Aydemir, J. Kerr, A. Schlesinger-raab, Peter Dirschedl, D. Hölzel (2003)
Determinants and prognoses of locoregional and distant progression in breast cancer.International journal of radiation oncology, biology, physics, 55 5
-
N. Lin, N. Ramakrishna, W. Younger, A. Storniolo, S. Come, R. Gelman, E. Eisenberg, E. Winer (2010)
Phase I study of lapatinib (L) in combination with whole-brain radiation therapy (WBRT) in patients (pts) with brain metastases from HER2-positive breast cancer.Journal of Clinical Oncology, 28
-
C. Christodoulou, D. Bafaloukos, P. Kosmidis, E. Samantas, A. Bamias, P. Papakostas, A. Karabelis, C. Bacoyiannis, D. Skarlos (2001)
Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases.Annals of oncology : official journal of the European Society for Medical Oncology, 12 2
-
C. Christodoulou, D. Bafaloukos, H. Linardou, G. Aravantinos, A. Bamias, M. Carina, G. Klouvas, D. Skarlos (2004)
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II studyJournal of Neuro-Oncology, 71
-
AF Eichler, I Kuter, P Ryan (2008)
Survival in patients with brain metastases from breast cancer: the importance of HER-2 statusCancer, 112
-
J. Hoffmann, I. Fichtner, M. Lemm, P. Lienau, H. Hess-Stumpp, A. Rotgeri, B. Hofmann, U. Klar (2009)
Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases.Neuro-oncology, 11 2
-
Y. Tsukada, A. Fouad, J. Pickren, W. Lane (1983)
Central nervous system metastasis from breast carcinoma autopsy studyCancer, 52
-
K. Miller, Molin Wang, J. Gralow, M. Dickler, M. Cobleigh, E. Perez, T. Shenkier, D. Cella, N. Davidson (2007)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.The New England journal of medicine, 357 26
-
M. Caraglia, R. Addeo, R. Costanzo, L. Montella, V. Faiola, M. Marra, A. Abbruzzese, G. Palmieri, A. Budillon, F. Grillone, S. Venuta, P. Tagliaferri, S. Prete (2005)
Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumoursCancer Chemotherapy and Pharmacology, 57
-
T. Bachelot, G. Romieu, M. Campone, Véronique Diéras, C. Cropet, H. Roché, M. Jimenez, E. Rhun, J-Y Pierga, A. Gonçalves, M. Leheurteur, J. Dômont, Maya Gutierrez, H. Curé, J. Ferrero, C. Labbé (2011)
LANDSCAPE: An FNCLCC phase II study with lapatinib (L) and capecitabine (C) in patients with brain metastases (BM) from HER2-positive (+) metastatic breast cancer (MBC) before whole-brain radiotherapy (WBR).Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 15_suppl
-
H. Aoyama, M. Tago, Norio Kato, T. Toyoda, M. Kenjyo, S. Hirota, H. Shioura, T. Inomata, E. Kunieda, K. Hayakawa, K. Nakagawa, Gen Kobashi, H. Shirato (2007)
Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.International journal of radiation oncology, biology, physics, 68 5
-
C. Oberhoff, D. Kieback, R. Würstlein, H. Deertz, J. Sehouli, C. Soest, J. Hilfrich, M. Mesrogli, G. Minckwitz, H. Staab, A. Schindler (2001)
Topotecan Chemotherapy in Patients with Breast Cancer and Brain Metastases: Results of a Pilot StudyOncology Research and Treatment, 24
-
J. Sarantopoulos, N. Gabrail, S. Moulder, A. Brenner, Carrie Smith, Danielle Bouchard, K. Elian, B. Lawrence, J. Castaigne, R. Kurzrock (2010)
ANG1005: Results of a phase I study in patients with advanced solid tumors and brain metastases.Journal of Clinical Oncology, 28
-
E. Azambuja, M. Lemort, J. Rossari, C. Moulin, A. Buttice, V. D'Hondt, F. Lebrun, Y. Lalami, F. Cardoso, C. Sotiriou, T. Gil, D. Devriendt, W. Marinus, M. Paesmans, M. Piccart, A. Awada (2011)
Phase I study of lapatinib (L) and temozolomide (T) combination for the treatment of progressive brain metastases (BM) in HER2-positive metastatic breast cancer patients (Pts) (LAPTEM, LAP 111172).Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 15_suppl
-
P Therasse, SG Arbuck, EA Eisenhauer (2000)
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaJ Natl Cancer Inst, 92
-
E. Rivera, C. Meyers, M. Groves, V. Valero, D. Francis, B. Arun, K. Broglio, G. Yin, G. Hortobagyi, T. Buchholz (2006)
Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinomaCancer, 107
-
E. Thomas, J. Tabernero, M. Fornier, P. Conte, P. Fumoleau, A. Lluch, L. Vahdat, C. Bunnell, H. Burris, P. Viens, J. Baselga, E. Rivera, V. Guarneri, V. Poulart, J. Klimovsky, D. Lebwohl, Miguel Martín (2007)
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 23
-
R. Freedman, E. Bullitt, Lixian Sun, R. Gelman, G. Harris, J. Ligibel, I. Krop, A. Partridge, E. Eisenberg, E. Winer, N. Lin (2011)
A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases.Clinical breast cancer, 11 6
-
A. Niwińska, M. Murawska, K. Pogoda (2010)
Breast cancer subtypes and response to systemic treatment after whole‐brain radiotherapy in patients with brain metastasesCancer, 116
-
H. Friedman, M. Prados, P. Wen, T. Mikkelsen, D. Schiff, L. Abrey, W. Yung, N. Paleologos, M. Nicholas, R. Jensen, J. Vredenburgh, Jane Huang, M. Zheng, T. Cloughesy (2009)
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 28
-
N. Lin, V. Diéras, D. Paul, D. Lossignol, C. Christodoulou, H. Stemmler, H. Roché, Minetta Liu, R. Greil, E. Ciruelos, S. Loibl, S. Gori, A. Wardley, D. Yardley, A. Brufsky, J. Blum, S. Rubin, B. Dharan, K. Steplewski, D. Zembryki, C. Oliva, D. Roychowdhury, P. Paoletti, E. Winer (2009)
Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast CancerClinical Cancer Research, 15
-
J. Barnholtz-Sloan, A. Sloan, F. Davis, F. Vigneau, P. Lai, R. Sawaya (2004)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 14
-
S. Siena, L. Crinò, M. Danova, S. Prete, S. Cascinu, S. Salvagni, I. Schiavetto, M. Vitali, E. Bajetta (2009)
Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II studyAnnals of Oncology, 21
-
V. Franciosi, G. Cocconi, M. Michiara, F. Costanzo, V. Fosser, M. Tonato, P. Carlini, C. Boni, S. Sarra (1999)
Front‐line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanomaCancer, 85
-
E. Bullitt, G. Gerig, S. Pizer, W. Lin, S. Aylward (2003)
Measuring tortuosity of the intracerebral vasculature from MRA imagesIEEE Transactions on Medical Imaging, 22
-
M. Melisko, D. Moore, P. Sneed, Julia Franco, H. Rugo (2008)
Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survivalJournal of Neuro-Oncology, 88
-
L. Abrey, Christos Christodoulou (2001)
Temozolomide for treating brain metastases.Seminars in oncology, 28 4 Suppl 13
-
A. Silvani, P. Gaviani, A. Fiumani, V. Scaioli, E. Lamperti, M. Eoli, A. Botturi, A. Salmaggi (2009)
Systemic sagopilone (ZK-EPO) treatment of patients with recurrent malignant gliomasJournal of Neuro-Oncology, 95
-
P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan, L. Rubinstein, J. Verweij, M. Glabbeke, A. Oosterom, M. Christian, S. Gwyther (2000)
New guidelines to evaluate the response to treatment in solid tumorsBreast Cancer, 12
-
Fancy Thomas, Kunal Taskar, Vinay Rudraraju, Satyanarayana Goda, H. Thorsheim, Julie Gaasch, R. Mittapalli, D. Palmieri, P. Steeg, P. Lockman, Q. Smith (2009)
Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast CancerPharmaceutical Research, 26
-
Y. Tham, K. Sexton, R. Kramer, S. Hilsenbeck, R. Elledge (2006)
Primary breast cancer phenotypes associated with propensity for central nervous system metastasesCancer, 107
-
H. Roché, L. Yelle, F. Cognetti, L. Mauriac, C. Bunnell, J. Sparano, P. Kerbrat, J. Delord, L. Vahdat, R. Peck, D. Lebwohl, R. Ezzeddine, H. Curé (2007)
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 23
-
R. Patchell, P. Tibbs, J. Walsh, R. Dempsey, Y. Maruyama, R. Kryscio, W. Markesbery, J. Macdonald, Byron Young (1990)
A randomized trial of surgery in the treatment of single metastases to the brain.The New England journal of medicine, 322 8
-
B. Nam, S. Kim, H. Han, Youngmee Kwon, K. Lee, Tae Kim, J. Ro (2008)
Breast cancer subtypes and survival in patients with brain metastasesBreast Cancer Research : BCR, 10
-
W. Boogerd, O. Dalesio, E. Bais, J. Sande (1992)
Response of brain metastases from breast cancer to systemic chemotherapyCancer, 69
- Publisher
- Springer Journals
- Copyright
- Copyright © 2011 by Springer Science+Business Media, LLC
- Subject
- Medicine & Public Health; Surgical Oncology; Oncology; Internal Medicine
- ISSN
- 1943-4588
- eISSN
- 1943-4596
- DOI
- 10.1007/s12609-011-0061-5
- Publisher site
- See Article on Publisher Site
Abstract
Approximately 10% to 15% of women with metastatic breast cancer will develop brain metastases. Treatment options for these women remain limited, particularly at the time of central nervous system (CNS) relapse following completion of initial CNS-directed therapy. Historically, prior studies have broadly examined systemic treatments for breast cancer brain metastases with mixed, but overall disappointing, results. More recently, studies have increasingly selected patients based on breast cancer subtype and have examined novel, targeted agents that have preclinical suggestion of blood–brain barrier penetration. Correlative science objectives, with both tissue-based and novel imaging endpoints, are more frequently incorporated into trials of this nature, with the goal of enhancing our understanding of possible predictors of response. This review summarizes the current and emerging data on systemic therapy for breast cancer brain metastases and provides a framework for future directions in treating this clinically-challenging entity.
Journal
Current Breast Cancer Reports – Springer Journals
Published: Dec 21, 2011